Methods for genetic modification of megakaryocytes and platelets.

about

RUNX1, but not its familial platelet disorder mutants, synergistically activates PF4 gene expression in combination with ETS family proteins.Recent developments in ex vivo platelet production.

P2860

Q33409055-AF214907-209D-4D54-8B1F-9B6CAFA86F84 Q38784723-A84557F4-A8F4-45CA-B94F-FA104D775409

P2860

Methods for genetic modification of megakaryocytes and platelets.

Item

http://www.wikidata.org/entity/Q36925626

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Methods for genetic modification of megakaryocytes and platelets.

@en

type

Item

label

Methods for genetic modification of megakaryocytes and platelets.

@en

prefLabel

Methods for genetic modification of megakaryocytes and platelets.

@en

P1476

Methods for genetic modification of megakaryocytes and platelets.

@en

P2093

Caroline Pendaries

http://www.w3.org/2001/XMLSchema#string

Jennifer C Spalton

http://www.w3.org/2001/XMLSchema#string

Stephen P Watson

http://www.w3.org/2001/XMLSchema#string

P2860

The molecular mechanisms that control thrombopoiesis

Megakaryocyte biology and related disorders

Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling.

FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia

Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1)

Affinity modulation of platelet integrin alphaIIbbeta3 by beta3-endonexin, a selective binding partner of the beta3 integrin cytoplasmic tail

Novel non-viral method for transfection of primary leukemia cells and cell lines

RNA interference is mediated by 21- and 22-nucleotide RNAs

Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis.

Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome

P304

393-408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09537100701288012

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17763148

http://www.w3.org/2001/XMLSchema#string

Methods for genetic modification of megakaryocytes and platelets.

about

P2860

P2860

Methods for genetic modification of megakaryocytes and platelets.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698